Evidence map›Paper›PMID 27138700›Full record

ArticlePloS one2016

HO-1 Protects against Hypoxia/Reoxygenation-Induced Mitochondrial Dysfunction in H9c2 Cardiomyocytes.

Dongling Chen, Zhe Jin, Jingjing Zhang, Linlin Jiang, Kai Chen, Xianghu He, Yinwei Song, Jianjuan Ke, Yanlin Wang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Regulation of autophagy of the heart in ischemia and reperfusion.Apoptosis : an international journal on programmed cell death · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Oxidative Stress in Ischemic Heart Disease.Oxidative medicine and cellular longevity · 2020
    Review
  11. Article
  12. Review
  13. Identification of potential molecular mechanisms and small molecule drugs in myocardial ischemia/reperfusion injury.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2020
    Article
  14. Shexiang Tongxin Dropping Pill () Protects against NaChinese journal of integrative medicine · 2019
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Dongling ChenDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhe JinDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jingjing ZhangDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Linlin JiangDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Kai ChenDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xianghu HeDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yinwei SongDepartment of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jianjuan KeDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yanlin WangDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wuhan University · CNZhongnan Hospital of Wuhan University · CNTongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMitochondrial dysfunction would ultimately lead to myocardial cell apoptosis and death during ischemia-reperfusion injuries. Autophagy could ameliorate mitochondrial dysfunction by autophagosome forming, which is a catabolic process to preserve the mitochondrial's structural and functional integrity. HO-1 induction and expression are important protective mechanisms. This study in order to investigate the role of HO-1 during mitochondrial damage and its mechanism. METHODS AND

resultsThe H9c2 cardiomyocyte cell line were incubated by hypoxic and then reoxygenated for the indicated time (2, 6, 12, 18, and 24 h). Cell viability was tested with CCK-8 kit. The expression of endogenous HO-1(RT-PCR and Western blot) increased with the duration of reoxygenation and reached maximum levels after 2 hours of H/R; thereafter, the expression gradually decreased to a stable level. Mitochondrial dysfunction (Flow cytometry quantified the ROS generation and JC-1 staining) and autophagy (The Confocal microscopy measured the autophagy. RFP-GFP-LC3 double-labeled adenovirus was used for testing.) were induced after 6 hours of H/R. Then, genetic engineering technology was employed to construct an Lv-HO1-H9c2 cell line. When HO-1 was overexpressed, the LC3II levels were significantly increased after reoxygenation, p62 protein expression was significantly decreased, the level of autophagy was unchanged, the mitochondrial membrane potential was significantly increased, and the mitochondrial ROS level was significantly decreased. Furthermore, when the HO-1 inhibitor ZnPP was applied the level of autophagy after reoxygenation was significantly inhibited, and no significant improvement in mitochondrial dysfunction was observed.

conclusionsDuring myocardial hypoxia-reoxygenation injury, HO-1 overexpression induces autophagy to protect the stability of the mitochondrial membrane and reduce the amount of mitochondrial oxidation products, thereby exerting a protective effect.

Indexed as

CytoprotectionAnimalsApoptosisAutophagyCell HypoxiaCell LineCell SurvivalEnzyme InductionEnzyme InhibitorsGene Expression Regulation, EnzymologicHeme Oxygenase-1MitochondriaMyocytes, CardiacOxygenProtoporphyrinsRatsEnzyme InhibitorsHeme Oxygenase-1OxygenProtoporphyrinszinc protoporphyrin

Identifiers

PMID27138700
PMCPMC4854406
OpenAlexW2346907194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.